Literature DB >> 12963622

Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer.

Prem S Subramanian1, John B Kerrison, Preston C Calvert, Neil R Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963622     DOI: 10.1001/archopht.121.9.1335

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  6 in total

1.  Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor.

Authors:  Puneet S Braich; Robin K Kuriakose; Naveen S Khokhar; Jared C Donaldson; Timothy J McCulley
Journal:  Int Ophthalmol       Date:  2017-06-20       Impact factor: 2.031

Review 2.  Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.

Authors:  Obi C Umunakwe; David Herren; Stephen J Kim; Sahar Kohanim
Journal:  Digit J Ophthalmol       Date:  2017-12-28

3.  Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  F Procianoy; E Procianoy
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

4.  Acute uveitis following zoledronic acid infusion.

Authors:  Krishna Kumar Rathnam; T G Sagar; Sanju Cyriac
Journal:  Oman J Ophthalmol       Date:  2009-05

Review 5.  Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.

Authors:  Yiming Tian; Rui Wang; Lianyuan Liu; Chunming Ma; Qiang Lu; Fuzai Yin
Journal:  BMC Musculoskelet Disord       Date:  2016-02-11       Impact factor: 2.362

Review 6.  Orbital Inflammation Caused by Aminobisphosphonates.

Authors:  J Gonzalez Barlatay; C Pagano Boza; G V Hernandez Gauna; J E Premoli
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.